These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32688200)

  • 1. Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: High-throughput virtual screening, synthesis and biological validation.
    Xiang S; Huang D; He Q; Li J; Tam KY; Zhang SL; He Y
    Eur J Med Chem; 2020 Oct; 203():112579. PubMed ID: 32688200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and structure-activity relationship of novel dichloroacetophenones targeting pyruvate dehydrogenase kinases with potent anticancer activity.
    Xu B; Wang ZP; Liu Q; Yang X; Li X; Huang D; Qiu Y; Tam KY; Zhang SL; He Y
    Eur J Med Chem; 2021 Mar; 214():113225. PubMed ID: 33550182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxicity screening to identify novel anti-osteosarcoma therapeutics targeting pyruvate dehydrogenase kinase 2.
    Cao W; Wang Z; Han X; Liu J; Wang W
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126665. PubMed ID: 31495556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.
    Wu DM; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Chen GQ; Zheng YL
    Eur J Med Chem; 2019 Feb; 164():252-262. PubMed ID: 30597326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
    Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of human lactate dehydrogenase a inhibitors: high-throughput screening, molecular dynamics simulation and enzyme activity assay.
    Shu Y; Yue J; Li Y; Yin Y; Wang J; Li T; He X; Liang S; Zhang G; Liu Z; Wang Y
    J Comput Aided Mol Des; 2024 Aug; 38(1):28. PubMed ID: 39123063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
    Guo F; Zhao S; Li X
    Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation.
    Gan L; Yang Y; Liang Z; Zhang M; He Y; Zhang SL
    Eur J Med Chem; 2024 Jan; 264():116008. PubMed ID: 38056298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel human lactate dehydrogenase A inhibitors: High-throughput screening, synthesis, and biological evaluations.
    Zhou Y; Tao P; Wang M; Xu P; Lu W; Lei P; You Q
    Eur J Med Chem; 2019 Sep; 177():105-115. PubMed ID: 31129449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics.
    Zhang W; Hu X; Chakravarty H; Yang Z; Tam KY
    ACS Comb Sci; 2018 Nov; 20(11):660-671. PubMed ID: 30350563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing.
    Zhou Y; Guo Y; Ran M; Shan W; Granchi C; Giovannetti E; Minutolo F; Peters GJ; Tam KY
    Cancer Lett; 2023 Nov; 577():216425. PubMed ID: 37805163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
    Zhang W; Hu X; Zhou W; Tam KY
    J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel fluorene derivatives as inhibitors of pyruvate dehydrogenase kinase.
    Inoue M; Nagamori H; Morita T; Kobayashi S; Suzawa K; Kitao Y; Saito T; Kawahara I; Orita T; Akai S; Adachi T; Motomura T
    Bioorg Med Chem Lett; 2024 Sep; 109():129839. PubMed ID: 38844173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of mitochondria-targeted pyruvate dehydrogenase kinase 1 inhibitors with improved selectivity and antiproliferative activity.
    Xu B; Yu Z; Xiang S; Li Y; Zhang SL; He Y
    Eur J Med Chem; 2018 Jul; 155():275-284. PubMed ID: 29890389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
    Zhang W; Zhang SL; Hu X; Tam KY
    Int J Biol Sci; 2015; 11(12):1390-400. PubMed ID: 26681918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 2-((3-cyanopyridin-2-yl)thio)acetamides as human lactate dehydrogenase A inhibitors to reduce the growth of MG-63 osteosarcoma cells: Virtual screening and biological validation.
    Cui W; Lv W; Qu Y; Ma R; Wang YW; Xu YJ; Wu D; Chen X
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3984-7. PubMed ID: 27406795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor potential induced by chloroacetate-loaded benzophenones acting as fused tubulin-pyruvate dehydrogenase kinase 1 (PDHK1) ligands.
    Ghinet A; Thuru X; Floquet E; Dubois J; Farce A; Rigo B
    Bioorg Chem; 2020 Mar; 96():103643. PubMed ID: 32035298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided discovery and biological characterization of human lactate dehydrogenase 5 inhibitors with anti-osteosarcoma activity.
    Cao W; Fang L; Teng S; Chen H; Wang Z
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2229-2233. PubMed ID: 29861142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichloroacetophenones targeting at pyruvate dehydrogenase kinase 1 with improved selectivity and antiproliferative activity: Synthesis and structure-activity relationships.
    Zhang SL; Yang Z; Hu X; Tam KY
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3441-3445. PubMed ID: 30266541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity.
    Kwak CH; Jin L; Han JH; Han CW; Kim E; Cho M; Chung TW; Bae SJ; Jang SB; Ha KT
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.